Skip to main content
SpringerLink
Log in

Clinical characteristics and antibiotic susceptibility of viridans streptococcal bacteremia in children with febrile neutropenia

  • Clinical and Epidemiological Study
  • Published:
Infection Aims and scope Submit manuscript

Abstract

Purpose

This retrospective study was performed in order to investigate the clinical characteristics and antibiotic susceptibility of viridans streptococcal bacteremia (VSB) in febrile neutropenic children in the context of the increase in incidence and antibiotic resistance of VSB.

Methods

We conducted this study among neutropenic children with underlying hematology/oncology diseases who were diagnosed with VSB at a single institution from April 2009 to June 2012. Clinical and laboratory characteristics of the children as well as antibiotic susceptibility of the causative viridans streptococci were evaluated.

Results

Fifty-seven episodes of VSB were diagnosed in 50 children. Severe complications occurred in four children (7.0 %), and a death of one child (1.8 %) was attributable to VSB. Acute myeloid leukemia was the most common underlying disease (70.2 % of all cases), and 71.9 % of all cases received chemotherapy including high-dose cytarabine. VSB occurred at a median of 13 days (range 8–21 days) after the beginning of chemotherapy, and fever lasted for a median of 4 days (range 1–21 days). The C-reactive protein level significantly increased within a week after the occurrence of VSB (p < 0.001) and the maximum C-reactive protein level showed a positive correlation with fever duration (r = 0.362, p = 0.007). Second blood cultures were done before the use of glycopeptides in 33 children, and negative results were observed in 30 children (90.9 %). Susceptibilities to cefotaxime, cefepime, and vancomycin were 58.9, 69.1, and 100 %, respectively.

Conclusions

Severe complications of VSB in neutropenic febrile children were rare. We suggest glycopeptide use according to the results of blood culture and antibiotic susceptibility tests based on the susceptibility to cefepime and the microbiologic response to empirical antibiotic treatment not including glycopeptides in this study.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

References

  1. Elting LS, Rubenstein EB, Rolston KV, Bodey GP. Outcomes of bacteremia in patients with cancer and neutropenia: observations from two decades of epidemiological and clinical trials. Clin Infect Dis. 1997;25:247–59.

    Article  PubMed  CAS  Google Scholar 

  2. Castagnola E, Fontana V, Caviglia I, et al. A prospective study on the epidemiology of febrile episodes during chemotherapy-induced neutropenia in children with cancer or after hemopoietic stem cell transplantation. Clin Infect Dis. 2007;45:1296–304.

    Article  PubMed  Google Scholar 

  3. Ko EY, Kang HJ, Kwon HJ, et al. Clinical investigation of bacteremia in children with hemato-oncologic diseases. Infect Chemother. 2011;43:191–7.

    Article  Google Scholar 

  4. Lee HJ, Lee JW, Kim JH, et al. A survey for causative organisms and antimicrobial susceptibilities of bacteremia in a single center children with hemato-oncologic diseases (2004–2006). Clin Pediatr Hematol Oncol. 2008;15:65–74.

    Google Scholar 

  5. Zinner SH. Changing epidemiology of infections in patients with neutropenia and cancer: emphasis on gram-positive and resistant bacteria. Clin Infect Dis. 1999;29:490–4.

    Article  PubMed  CAS  Google Scholar 

  6. Freifeld AG, Bow EJ, Sepkowitz KA, et al. Clinical practice guideline for the use of antimicrobial agents in neutropenic patients with cancer: 2010 update by the infectious diseases society of America. Clin Infect Dis. 2011;52:e56–93.

    Article  PubMed  Google Scholar 

  7. Lee DG, Kim SH, Kim SY, et al. Evidence-based guidelines for empirical therapy of neutropenic fever in Korea. Korean J Intern Med. 2011;26:220–52.

    Article  PubMed  CAS  Google Scholar 

  8. Hakim H, Flynn PM, Knapp KM, Srivastava DK, Gaur AH. Etiology and clinical course of febrile neutropenia in children with cancer. J Pediatr Hematol Oncol. 2009;31:623–9.

    Article  PubMed  Google Scholar 

  9. Bruckner L, Gigliotti F. Viridans group streptococcal infections among children with cancer and the importance of emerging antibiotic resistance. Semin Pediatr Infect Dis. 2006;17:153–60.

    Article  PubMed  Google Scholar 

  10. Husain E, Whitehead S, Castell A, Thomas EE, Speert DP. Viridans streptococci bacteremia in children with malignancy: relevance of species identification and penicillin susceptibility. Pediatr Infect Dis J. 2005;24:563–6.

    Article  PubMed  Google Scholar 

  11. Marron A, Carratalà J, González-Barca E, Fernández-Sevilla A, Alcaide F, Gudiol F. Serious complications of bacteremia caused by Viridans streptococci in neutropenic patients with cancer. Clin Infect Dis. 2000;31:1126–30.

    Article  PubMed  CAS  Google Scholar 

  12. Wheeler AP, Bernard GR. Acute lung injury and the acute respiratory distress syndrome: a clinical review. Lancet. 2007;369:1553–64.

    Article  PubMed  Google Scholar 

  13. Gassas A, Grant R, Richardson S, et al. Predictors of viridans streptococcal shock syndrome in bacteremic children with cancer and stem-cell transplant recipients. J Clin Oncol. 2004;22:1222–7.

    Article  PubMed  Google Scholar 

  14. Paganini H, Staffolani V, Zubizarreta P, Casimir L, Lopardo H, Luppino V. Viridans streptococci bacteraemia in children with fever and neutropenia: a case–control study of predisposing factors. Eur J Cancer. 2003;39:1284–9.

    Article  PubMed  CAS  Google Scholar 

  15. Richard P, Amador Del Valle G, Moreau P, et al. Viridans streptococcal bacteraemia in patients with neutropenia. Lancet. 1995;345:1607–9.

    Article  PubMed  CAS  Google Scholar 

  16. Rossetti F, Cesaro S, Putti MC, Zanesco L. High-dose cytosine arabinoside and viridans Streptococcus sepsis in children with leukemia. Pediatr Hematol Oncol. 1995;12:387–92.

    Article  PubMed  CAS  Google Scholar 

  17. Tunkel AR, Sepkowitz KA. Infections caused by viridans streptococci in patients with neutropenia. Clin Infect Dis. 2002;34:1524–9.

    Article  PubMed  Google Scholar 

  18. Reilly AF, Lange BJ. Infections with viridans group streptococci in children with cancer. Pediatr Blood Cancer. 2007;49:774–80.

    Article  PubMed  Google Scholar 

  19. Ahmed R, Hassall T, Morland B, Gray J. Viridans Streptococcus bacteremia in children on chemotherapy for cancer: an underestimated problem. Pediatr Hematol Oncol. 2003;20:439–44.

    PubMed  CAS  Google Scholar 

  20. Spanik S, Trupl J, Kunova A, et al. Viridans streptococcal bacteraemia due to penicillin-resistant and penicillin-sensitive streptococci: analysis of risk factors and outcome in 60 patients from a single cancer centre before and after penicillin is used for prophylaxis. Scand J Infect Dis. 1997;29:245–9.

    Article  PubMed  CAS  Google Scholar 

  21. Gabay C, Kushner I. Acute-phase proteins and other systemic responses to inflammation. N Engl J Med. 1999;340:448–54.

    Article  PubMed  CAS  Google Scholar 

  22. Engel A, Kern P, Kern WV. Levels of cytokines and cytokine inhibitors in the neutropenic patient with alpha-hemolytic Streptococcus shock syndrome. Clin Infect Dis. 1996;23:785–9.

    Article  PubMed  CAS  Google Scholar 

  23. Ihendyane N, Sparrelid E, Wretlind B, et al. Viridans streptococcal septicaemia in neutropenic patients: role of proinflammatory cytokines. Bone Marrow Transplant. 2004;33:79–85.

    Article  PubMed  CAS  Google Scholar 

  24. Soto A, McWhinney PH, Kibbler CC, Cohen J. Cytokine release and mitogenic activity in the viridans streptococcal shock syndrome. Cytokine. 1998;10:370–6.

    Article  PubMed  CAS  Google Scholar 

  25. Ward MA, Lentzsch-Parcells CL. Fever: pathogenesis and treatment. In: Feigin RD, Cherry JD, Demmler-Harrison GJ, Kaplan SL, editors. Feigin and Cherry’s textbook of pediatric infectious diseases. 6th ed. Philadelphia: Saunders; 2009. p. 105–10.

    Google Scholar 

  26. Han XY, Kamana M, Rolston KV. Viridans streptococci isolated by culture from blood of cancer patients: clinical and microbiologic analysis of 50 cases. J Clin Microbiol. 2006;44:160–5.

    Article  PubMed  Google Scholar 

  27. Karp JE, Dick JD, Angelopulos C, et al. Empiric use of vancomycin during prolonged treatment-induced granulocytopenia. Randomized, double-blind, placebo-controlled clinical trial in patients with acute leukemia. Am J Med. 1986;81:237–42.

    Article  PubMed  CAS  Google Scholar 

  28. Paul M, Borok S, Fraser A, Vidal L, Leibovici L. Empirical antibiotics against Gram-positive infections for febrile neutropenia: systematic review and meta-analysis of randomized controlled trials. J Antimicrob Chemother. 2005;55:436–44.

    Article  PubMed  CAS  Google Scholar 

  29. Ramphal R. Changes in the etiology of bacteremia in febrile neutropenic patients and the susceptibilities of the currently isolated pathogens. Clin Infect Dis. 2004;39(Suppl 1):S25–31.

    Article  PubMed  Google Scholar 

  30. Rubin M, Hathorn JW, Marshall D, Gress J, Steinberg SM, Pizzo PA. Gram-positive infections and the use of vancomycin in 550 episodes of fever and neutropenia. Ann Intern Med. 1988;108:30–5.

    Article  PubMed  CAS  Google Scholar 

Download references

Conflict of interest

There is no conflict of interest and no source of funding for all authors.

Author information

Authors and Affiliations

  1. Department of Pediatrics, Seoul St. Mary’s Hospital, College of Medicine, The Catholic University of Korea, 222, Banpo-daero, Seocho-gu, Seoul, Republic of Korea

    S. B. Han, E. Y. Bae, J. W. Lee, N. G. Chung, D. C. Jeong, B. Cho, J. H. Kang & H. K. Kim

  2. Division of Infectious Diseases, Department of Internal medicine, Seoul St. Mary’s Hospital, College of Medicine, The Catholic University of Korea, 222, Banpo-daero, Seocho-gu, Seoul, Republic of Korea

    D. G. Lee

Authors
  1. S. B. Han
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. E. Y. Bae
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. J. W. Lee
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. D. G. Lee
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. N. G. Chung
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. D. C. Jeong
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. B. Cho
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. J. H. Kang
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. H. K. Kim
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to J. H. Kang.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Han, S.B., Bae, E.Y., Lee, J.W. et al. Clinical characteristics and antibiotic susceptibility of viridans streptococcal bacteremia in children with febrile neutropenia. Infection 41, 917–924 (2013). https://doi.org/10.1007/s15010-013-0470-7

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s15010-013-0470-7

Keywords

Search

Navigation